Showing results (531-540 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|March 13, 2019
Drug-Drug Interactions of Tacrolimus or Cyclosporine With Glecaprevir and Pibrentasvir in Healthy SubjectsMatthew P Kosloski, Weihan Zhao, Hong Li, et al.
Clinical Pharmacology in Drug Development|November 15, 2018
Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/MetforminVaishali Sahasrabudhe, Daryl J Fediuk, Kyle Matschke, et al.
Clinical Pharmacology in Drug Development|November 10, 2018
An Open-Label, Single-Dose, Human Mass Balance Study of Amenamevir in Healthy Male AdultsKota Kato, Martin den Adel, Dorien Groenendaal-van de Meent, et al.
Clinical Pharmacology in Drug Development|January 28, 2017
An Open-Label, Randomized Bioavailability Study of Alternative Methods of Oral Administration of Naloxegol in Healthy SubjectsKhanh Bui, Bruce Birmingham, Ulysses Diva, et al.
Clinical Pharmacology in Drug Development|April 11, 2017
Randomized, Blinded, Placebo- and Positive-Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy SubjectsCaroline Fradette, Anna Rozova, Anne Stilman, et al.
Clinical Pharmacology in Drug Development|April 22, 2017
Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake ConditionsWan Sun, Karen J Klamerus, Lisa M Yuhas, et al.
Clinical Pharmacology in Drug Development|April 19, 2017
A Phase 1 Randomized, Placebo-Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese SubjectsStephen Caltabiano, Mindy He Magee, Feng Liu, et al.
Clinical Pharmacology in Drug Development|April 14, 2017
No Pharmacokinetic Drug-Drug Interaction Between Prasugrel and Vorapaxar Following Multiple-Dose Administration in Healthy VolunteersMatt S Anderson, Teddy Kosoglou, Paul Statkevich, et al.
Pageof 136